Institutional investors purchased a net $1.8 million shares of SPPI during the quarter ended December 2013 and now own 75.60% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
GOLDMAN SACHS & CO. (PRIVATE BAN... Bought 1.3 Million shares of Spectrum Pharmaceuticals ...
RBC CAPITAL MARKETS LLC Bought 1.2 Million shares of Spectrum Pharmaceuticals ...